A targeted genomic analysis uncovered a large spectrum of acquired resistance mechanisms to BRAF inhibitor therapy in metastatic melanoma patients

Saved in:
Bibliographic Details
Published inAnnals of oncology Vol. 29; pp. iii25 - iii26
Main Authors Louveau, B., Reger de Moura, C., Battistella, M., Sadoux, A., Chami, I., Caramel, J., Dalle, S., Dumaz, N., Lebbe, C., Mourah, S.
Format Journal Article
LanguageEnglish
Published Elsevier Ltd 01.03.2018
Online AccessGet full text

Cover

Loading…
More Information
ISSN:0923-7534
1569-8041
DOI:10.1093/annonc/mdy047.063